Applications including "USP draft"

GA397 - Analysis of Nitromethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Nitromethane) -

GC InertSearch InertCap 624MS
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC InertSearch InertSustain AQ-C18
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustainC18
LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC InertSearch InertCore C8
LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC InertSearch InertSustain C8
LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC InertSearch InertSustain C8
LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC InertSearch InertSustain C8
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC InertSearch InertSustainSwift C18
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC InertSearch InertSustainSwift C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC InertSearch InertSustain C18
LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LC InertSearch Inertsil NH2
GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

GC InertSearch InertCap FFAP
LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB974 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB965 - Analysis of Nicardipine Hydrochloride -

LC InertSearch InertSustain C8
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LC InertSearch Insertsil Ph-3
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB925 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB924 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB919 - Analysis of Pitavastatin Calcium -

LC InertSearch InertCore Plus C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA352 - Analysis of Dipropylene Glycol -

GC InertSearch InertCap WAX-HT
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl

Applications including "USP draft"

GA397 - Analysis of Nitromethane(Under the Condition of draft for USP, Tromethamine Hydrochloride, Limit of Nitromethane) -

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC012 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

GA387 - Analysis of Ethanol and Acetonitrile (Under the Condition for the Draft for USP, Tavaborole Topical Solution, Content of Alcohol) -

LB990 - Analysis of Xylazine -

LB989 - Analysis of Xylazine -

LB988 - Analysis of Xylazine -

LB987 - Analysis of Xylazine -

LB974 - Analysis of Dapagliflozin propandiol -

LB965 - Analysis of Nicardipine Hydrochloride -

LB958 - Analysis of Methyltestosterone and Progesterone -

LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LB947 - Analysis of Glacial Acetic Acid -

LB946 - Analysis of Glacial Acetic Acid -

LB945 - Analysis of Glacial Acetic Acid -

LB931 - Analysis of Acyclovir -

LB925 - Analysis of Acyclovir -

LB924 - Analysis of Acyclovir -

LB919 - Analysis of Pitavastatin Calcium -

LB914 - Analysis of Saxagliptin -

LB913 - Analysis of Saxagliptin -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -

LB900 - Analysis of Fesoterodine Fumarate -

LB899 - Analysis of Fesoterodine Fumarate -

GA352 - Analysis of Dipropylene Glycol -

LB896 - Analysis of Triptorelin Pamoate -

LB895 - Analysis of Venlafaxine hydrochloride -

LB891 - Analysis of Saxagliptin -

LB890 - Analysis of Saxagliptin -

LB889 - Analysis of Propyl gallate -

LB888 - Analysis of Propyl gallate -

LB887 - Analysis of Propyl gallate -

LB885 - Analysis of Voriconazole -

LB884 - Analysis of Voriconazole -

LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

Application Search